358 Trial in progress: A pilot study of combined immune checkpoint inhibition in combination with ablative therapies in subjects with hepatocellular carcinoma (HCC)

• Peter Doran,
• Marie Galligan,
• Ronan Ryan,
• Austin Duffy,
• Tim Greten,
• Hailey Carroll,
• Umair Aleem,
• Pooja Varghese,
• Michèle Bourke,
• Katherine Hoey,
• Stephen Stewart,
• Cliona O’Farrelly,
• Diarmaid Houlihan,
• Raymond McDermott

Affiliations

Peter Doran

UCD Clinical Research Centre, School of Medicine, University College Dublin, Dublin, Ireland

Marie Galligan

UCD Clinical Research Centre, School of Medicine, University College Dublin, Dublin, Ireland

Ronan Ryan

2St. Vincent’s University Hospital, Dublin, Ireland

Austin Duffy

Aff2 grid.48336.3a0000000419368075NCI/NIH USA

Tim Greten

Aff1 grid.417768.b0000000404839129Center for Cancer Research, NCI Bethesda MD USA

Hailey Carroll

1Mater Hospital, Dublin, Ireland

Umair Aleem

2St. Vincent’s University Hospital, Dublin, Ireland

Pooja Varghese

3University College Dublin, Dublin, Ireland

Michèle Bourke

2St. Vincent’s University Hospital, Dublin, Ireland

Katherine Hoey

2St. Vincent’s University Hospital, Dublin, Ireland

Stephen Stewart

1Mater Hospital, Dublin, Ireland

Cliona O’Farrelly

4Trinity College, Dublin, Ireland

Diarmaid Houlihan

2St. Vincent’s University Hospital, Dublin, Ireland

Raymond McDermott

2St. Vincent’s University Hospital, Dublin, Ireland